Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/7521905

Download in:

View as

General Info

PMID
7521905